LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Altos Labs Inc.
Headquarters:
San Francisco, CA, United States
Website:
http://www.altoslabs.com
Year Founded:
2021
Status:
Private
BioCentury
|
Sep 26, 2024
Finance
Eyes on Europe: Asabys’ €180M fund, Genespire’s record series B
BioCentury’s weekly Venture Report also includes Arch’s latest fund, Flagship-backed Mirai, series Bs for Vicebio and 858, and more
Read More
BioCentury
|
Sep 26, 2024
Discovery & Translation
Science Spotlight: Targeted protein relocalization, rejuvenating aged eggs, and more
BioCentury’s roundup of translational innovations
Read More
BioCentury
|
Nov 3, 2023
Discovery & Translation
Dimeric IgA targets intracellular oncogenes; plus taRNAs and more
BioCentury’s roundup of translational innovations
Read More
BioCentury
|
Aug 25, 2023
Finance
Making Mubadala Capital Ventures
How the sovereign’s venture arm has integrated itself into the biotech ecosystem and become a company builder
Read More
BioCentury
|
Jul 21, 2023
Management Tracks
Ann Lee-Karlon named CEO of EpiBiologics
Plus: Haas becomes CEO at LimmaTech, and updates from Sagimet, Agenus, Triumvira and Passage Bio
Read More
BioCentury
|
Jul 14, 2022
Management Tracks
New CEO at Deerfield-backed Apertura
Plus 10x Genomics hires Wilbur to head commercial, and updates from Immune-Onc, PathAI, Sherlock and more
Read More
BioCentury
|
Jun 30, 2022
Finance
With $3B fund, Arch seeks long-term alignment with LPs, start-ups
Veteran firm aiming to invest biggest-ever Fund XII in companies with high-impact, transformational goals
Read More
BioCentury
|
Jan 20, 2022
Product Development
Barron’s departure leaves unfinished business in GSK’s cancer pipeline
CSO stepping down to join biopharma ‘dream team’ at newly launched Altos
Read More
Items per page:
10
1 - 8 of 8
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help